NEWLINK GENETICS CORP's ticker is NLNK and the CUSIP is 651511107. A total of 109 filers reported holding NEWLINK GENETICS CORP in Q2 2018. The put-call ratio across all filers is 1.64 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $30,000 | -31.8% | 19,942 | -13.5% | 0.00% | -33.3% |
| Q1 2019 | $44,000 | -45.0% | 23,047 | -56.0% | 0.00% | -50.0% |
| Q4 2018 | $80,000 | -42.0% | 52,324 | -9.7% | 0.01% | -40.0% |
| Q3 2018 | $138,000 | -53.7% | 57,924 | -7.5% | 0.01% | -54.5% |
| Q2 2018 | $298,000 | -31.3% | 62,614 | +4.5% | 0.02% | -33.3% |
| Q1 2018 | $434,000 | -86.7% | 59,921 | -86.5% | 0.03% | -86.1% |
| Q2 2017 | $3,257,000 | +700.2% | 443,256 | +2523.1% | 0.24% | +746.4% |
| Q1 2017 | $407,000 | -77.5% | 16,898 | -90.4% | 0.03% | -77.6% |
| Q4 2016 | $1,810,000 | -45.1% | 176,077 | -19.8% | 0.12% | -47.5% |
| Q3 2016 | $3,297,000 | -36.4% | 219,571 | -52.3% | 0.24% | -33.7% |
| Q2 2016 | $5,181,000 | -35.1% | 460,146 | +4.9% | 0.36% | -32.6% |
| Q1 2016 | $7,982,000 | +361.4% | 438,593 | +822.2% | 0.53% | +326.4% |
| Q4 2015 | $1,730,000 | -84.4% | 47,557 | -84.7% | 0.12% | -84.2% |
| Q3 2015 | $11,109,000 | -19.0% | 309,984 | 0.0% | 0.79% | -22.9% |
| Q2 2015 | $13,722,000 | – | 309,984 | – | 1.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NORTHWEST WEALTH MANAGEMENT, LLC | 54,282 | $553,000 | 0.77% |
| Redmile Group, LLC | 1,248,700 | $12,712,000 | 0.63% |
| FT Options LLC | 20,796 | $212,000 | 0.32% |
| Perceptive Advisors | 900,000 | $9,162,000 | 0.18% |
| Rhenman & Partners Asset Management AB | 100,000 | $1,018,000 | 0.13% |
| PDT Partners, LLC | 349,981 | $3,563,000 | 0.12% |
| Alambic Investment Management, L.P. | 105,370 | $1,073,000 | 0.12% |
| Endurant Capital Management LP | 36,100 | $367,000 | 0.11% |
| GSA CAPITAL PARTNERS LLP | 132,154 | $1,345,000 | 0.09% |
| COLUMBUS CIRCLE INVESTORS | 485,848 | $4,946,000 | 0.08% |